Carbamazepine was given to 12 chronic, treatment-refractory
schizophrenic patients for 5 weeks. No overall change was found, but four
patients significantly improved while eight worsened. Given the paucity of
successful treatments for refractory schizophrenia, further study of
carbamazepine appears warranted.
Abstract Teaser